Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

OpenAI wraps $7 billion share sale ahead of potential IPO

3 weeks ago 8

PROTECT YOURSELF with Orgo-Life® QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

OpenAI CEO Sam Altman walks between meetings on Capitol Hill, in Washington, U.S., July 29, 2026.

Nathan Howard | Reuters

OpenAI completed a secondary share sale totaling roughly $7 billion, allowing current and former employees to sell stock at the company's $852 billion valuation, CNBC confirmed on Monday.

The tender offer has been in the works since OpenAI closed its record-breaking $122 billion funding round in March. The deal will help alleviate some near-term pressure for liquidity, allowing employees to cash in a portion of their holdings ahead the company's potentially massive IPO.

Bloomberg was first to report the $7 billion figure.

OpenAI rocketed into the mainstream following the launch of its ChatGPT chatbot in 2022, and it's ballooned into one of the fastest-growing private companies on the planet in the years since. The company confidentially filed its prospectus with the Securities and Exchange Commission in June, but hasn't disclosed an official timeline for its debut. Rival Anthropic is in a similar position.

Secondary sales have become part of OpenAI's pre-IPO strategy. The company completed a $6.6 billion tender offer at a $500 billion valuation in October, and a $1.5 billion tender offer in 2024.

—CNBC's Kate Rooney contributed to this report

WATCH: Big Tech’s Anthropic, OpenAI stakes distort S&P earnings picture

Big Tech's Anthropic, OpenAI stakes distort S&P earnings picture

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway